One of the crucial aspects of effective cancer patient monitoring is the detection of cancerous cells in the blood stream. The CEP will provide an effective platform for cancer diagnosis, metastasis and monitoring.
The CEP Advantage
The CEP is a flow through technology that yields a larger number of viable cells, with increased purity in comparison to leading separation methods.
Market Opportunity
Cancer detection and monitoring is a huge market, with over 9 million tests performed annually in the US alone. This represents a $1 billion annual market opportunity for BioCep.
